ResearcherKyoto Prefectural University of MedicineActive in the last 2 years
Yoshito Itoh
Matched on ORCID iD 0000-0001-9890-3635; OpenAlex author ID A5038459903, A5110044871. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 0, last author 9)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 11
- Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. Co-author DOI 10.21873/anticanres.18260↗
- Current status of cancer genome medicine for pancreatic ductal adenocarcinoma. Last author DOI 10.1093/jjco/hyaf012↗
- Epithelial-Mesenchymal Transition Suppression by ML210 Enhances Gemcitabine Anti-Tumor Effects on PDAC Cells. Co-author DOI 10.3390/biom15010070↗
- Real-world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications. Last author DOI 10.1111/cas.16329↗
- Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Last author DOI 10.1007/s00535-023-01986-9↗
- Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy. Last author DOI 10.1159/000522639↗
- Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer. Last author DOI 10.3390/cancers13153860↗
- Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Last author DOI 10.1038/s41598-020-75745-8↗
- Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. Last author DOI 10.3892/or.2020.7595↗
- The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines. Last author DOI 10.3892/or.2017.5399↗
- The inhibitory effect of heat treatment against epithelial-mesenchymal transition (EMT) in human pancreatic adenocarcinoma cell lines. Last author DOI 10.3164/jcbn.14-8↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toshifumi Doi · 5 shared papers, 2017–2026 · strength 0.99
- Paper Current status of cancer genome medicine for pancreatic ductal adenocarcinoma. DOI 10.1093/jjco/hyaf012↗
- Paper Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. DOI 10.21873/anticanres.18260↗
- Paper Real-world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications. DOI 10.1111/cas.16329↗
- Takeshi Ishikawa · 6 shared papers, 2014–2025 · strength 0.88
- Paper Current status of cancer genome medicine for pancreatic ductal adenocarcinoma. DOI 10.1093/jjco/hyaf012↗
- Paper Real-world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications. DOI 10.1111/cas.16329↗
- Paper Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of J… DOI 10.1007/s00535-023-01986-9↗
- N. Iwai · 4 shared papers, 2020–2026 · strength 0.56
- Paper Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. DOI 10.21873/anticanres.18260↗
- Paper Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Rec… DOI 10.1159/000522639↗
- Paper Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresecta… DOI 10.3390/cancers13153860↗
- Tomoki Sakakida · 3 shared papers, 2023–2026 · strength 0.56
- Paper Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. DOI 10.21873/anticanres.18260↗
- Paper Real-world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications. DOI 10.1111/cas.16329↗
- Paper Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of J… DOI 10.1007/s00535-023-01986-9↗
- Keisuke Takemura · 2 shared papers, 2025–2026 · strength 0.47
- Kyohei Ikeda · 2 shared papers, 2025–2026 · strength 0.47
- Tomohisa Takagi · 4 shared papers, 2014–2026 · strength 0.42
- Paper Potential Role of Proton Beam Therapy for Locally Advanced Pancreatic Cancer. DOI 10.21873/anticanres.18260↗
- Paper Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. DOI 10.3892/or.2020.7595↗
- Paper The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines. DOI 10.3892/or.2017.5399↗
- Koichi Takayama · 2 shared papers, 2023–2024 · strength 0.33
- Paper Real-world genome profiling in Japanese patients with pancreatic ductal adenocarcinoma focusing on HRD implications. DOI 10.1111/cas.16329↗
- Paper Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of J… DOI 10.1007/s00535-023-01986-9↗
- Atsushi Umemura · 1 shared paper, 2025 · strength 0.24
- Juichiro Yoshida · 1 shared paper, 2020 · strength 0.09
- Reiko Kimura‐Tsuchiya · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.